First American Bank decreased its position in Danaher Corporation (NYSE:DHR – Free Report) by 0.1% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 77,658 shares of the conglomerate’s stock after selling 66 shares during the quarter. Danaher accounts for approximately 1.1% of First American Bank’s holdings, making the stock its 23rd biggest holding. First American Bank’s holdings in Danaher were worth $15,341,000 at the end of the most recent reporting period.
Several other large investors have also made changes to their positions in DHR. GHP Investment Advisors Inc. grew its stake in Danaher by 396.0% during the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock worth $25,000 after buying an additional 99 shares during the last quarter. Sierra Ocean LLC grew its position in Danaher by 116.9% during the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock worth $29,000 after acquiring an additional 76 shares during the last quarter. Smallwood Wealth Investment Management LLC bought a new stake in Danaher during the 1st quarter worth approximately $31,000. Dunhill Financial LLC grew its position in Danaher by 68.4% during the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate’s stock worth $34,000 after acquiring an additional 67 shares during the last quarter. Finally, Costello Asset Management INC bought a new stake in shares of Danaher during the first quarter worth $41,000. Institutional investors own 79.05% of the company’s stock.
Insider Activity
In other news, Director Teri List sold 2,778 shares of the business’s stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the transaction, the director directly owned 20,751 shares in the company, valued at approximately $4,379,706.06. The trade was a 11.81% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 11.10% of the company’s stock.
Wall Street Analyst Weigh In
Check Out Our Latest Research Report on Danaher
Danaher Price Performance
Shares of DHR stock opened at $184.97 on Friday. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $279.59. The stock has a market cap of $132.45 billion, a PE ratio of 39.36, a PEG ratio of 2.59 and a beta of 0.75. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. The firm’s 50 day moving average price is $199.44 and its two-hundred day moving average price is $197.58.
Danaher (NYSE:DHR – Get Free Report) last announced its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The firm had revenue of $5.94 billion for the quarter, compared to analysts’ expectations of $5.83 billion. During the same period last year, the firm earned $1.72 earnings per share. The business’s revenue for the quarter was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, analysts forecast that Danaher Corporation will post 7.63 EPS for the current year.
Danaher Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be issued a dividend of $0.32 per share. The ex-dividend date is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a yield of 0.7%. Danaher’s dividend payout ratio (DPR) is 27.23%.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Stories
- Five stocks we like better than Danaher
- What is the Dow Jones Industrial Average (DJIA)?
- Pfizer is Locking in New Growth Through a New Acquisition
- ESG Stocks, What Investors Should Know
- Copper Giant Freeport Slumps but Analysts See 33% Upside
- Pets Are Big Business: 4 Big-Ticket Pet Stocks to Add to Your Portfolio
- The BYD Opportunity: Tesla-Like Growth at a Fraction of the Price
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.